Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer

BACKGROUND: There are many studies on neoadjuvant immunotherapy for locally advanced non‐small cell lung cancer (NSCLC) patients. Expert consensus recommends neoadjuvant immunotherapy for patients with resectable stage IB–IIIA NSCLC. However, there are few clinical studies or cases to verify this. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Tao, Sun, Teng, Zhang, Miao, Liu, Xinlong, Yuan, Yanliang, Dolo, Ponnie Robertlee, Chen, Bi, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520798/
https://www.ncbi.nlm.nih.gov/pubmed/34463034
http://dx.doi.org/10.1111/1759-7714.14127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520798/
https://www.ncbi.nlm.nih.gov/pubmed/34463034
http://dx.doi.org/10.1111/1759-7714.14127

Ejemplares similares